Our Leadership
A team of bright minds with an even brighter mission.
If you’ve read The Sapio Seven, you know that we are a mission-driven organization with the heart of a scientist. We sincerely believe that being the company we were born to be begins with leadership. Our management team and advisory board embody all of our core values and strengthen our daily work with their scientific, technological, and operational experience.
- Management Team
- Board of Directors
Jim Datin
Chair, Board
Jim Datin is a seasoned executive with extensive expertise in the Pharmaceutical, Life Sciences, Medical Device, Diagnostics, and Biotech industries. Throughout his career, he has excelled as a CEO, director, and executive, holding key positions in various companies across the United States, Canada, Europe, and Asia. With a track record of more than 40 successful transactions, including venture investments, buyouts, acquisitions, mergers, IPOs, licensing, and partnership agreements, Jim has established himself as a formidable force in the business world.
Previously, Jim served as the President and CEO of BioAgilytix, a prominent provider of contract bioanalytical testing services specializing in bioanalysis. Under his leadership, BioAgilytix achieved notable recognition, appearing on the Inc. 5000 list of Fastest Growing Companies for consecutive years from 2013 to 2020. The company also garnered acclaim for its award-winning customer service and remarkable employee retention rates, which are among the highest in the industry.
Currently, Jim has shifted his focus to supporting and advancing the success of private equity and venture-backed companies. Additionally, he actively engages in global philanthropic initiatives, demonstrating his commitment to making a positive impact on a global scale.
Jim Datin
Chair, Board
Jim is a seasoned executive with extensive expertise in the Pharmaceutical, Life Sciences, Medical Device, Diagnostics, and Biotech industries.
Edward de Nor
Partner, GHO Partners
Edward is an experienced private equity executive with over 25 years of financial and principal investing experience focused on the European and North American mid-market.
With former roles including Partner at G Square Healthcare Private Equity, Founder at Carrycastle and as Head of UK & Northern European private equity at Goldman Sachs PIA, Edward has focused his career on supporting mid-market companies to grow on both sides of the Atlantic. Edward began his career with IBM in engineering and corporate development, working then with technologies that are prevalent in the healthcare industry today.
Edward currently sits on the boards of Sapio Sciences, Biocare Medical, Velocity and FairJourney Biologics and previously BioAgilytix and DDC until their successful exits.
He holds a Bachelor of Science degree from Texas A&M University and an MBA from the Jesse H. Jones Graduate School of Business at Rice University. Edward has lived and worked throughout the USA, UK and continental Europe and speaks French.
Edward de Nor
Partner, GHO Partners
Edward is an experienced private equity executive with over 25 years of financial and principal investing experience.
Mike Turner
Partner, GHO Partners
Mike is an experienced private equity investor with a more than 20 year track record in growth equity, buyouts, carve-outs, turnarounds, structured equity and quoted equity investments.
With previous roles including Partner & Head of UK Healthcare at 3i and Head of Principal Investments EMEA at Macquarie, Mike has originated, executed, managed and successfully exited investments across many industry sectors in the European mid-market including healthcare investments such as Westminster Healthcare and Care Principles. He began his career with an operating role at Mobil Oil UK, where he managed a £30 million turnover business for the Retail Fuels Division.
Mike is currently on the boards of Sapio Sciences, Validant, Linimed and VISUfarma and has worked closely with the management teams of Quotient Sciences and Envision Pharma Group.
He has a degree in Management & Systems from City University and an MBA from Cranfield School of Management. From the UK, Mike has led deals on both sides of the Atlantic as well as throughout Europe.
Mike Turner
Partner, GHO Partners
Mike provides a more than 20 year track record in growth equity, buyouts, carve-outs, turnarounds, structured equity and quoted equity investments.
Kevin Cramer
Founder & Chief Executive Officer
Kevin Cramer serves as the founder and CEO of Sapio Sciences, leveraging a wealth of tech expertise to lead product design and development within the company. His dynamic career includes strategic roles at tech and life sciences companies such as Siebel Systems, Sybase, Biomind, and Veloxity, with a unique skill set that blends technical acumen and sales prowess.
A well-established authority in the lab informatics field, Kevin’s professional footprint extends to his contributions to various papers in Nature Genetics, where he applied statistical and machine learning methodologies to the interpretation of genetic data. His educational background includes a Bachelor’s Degree in Information Systems from York College, PA.
At the helm of Sapio Sciences, Kevin is driven by his dedication to accelerating the drug R&D process. His vision encompasses a unified platform designed to streamline the creation of large and small molecules, assess their efficacy, manage data capture at scale, and harness the power of data visualization. The platform also incorporates advanced analytical and AI strategies to augment the discovery process.
Beyond the professional sphere, Kevin finds balance in his love for sports, being an ardent fan of Penn State football and the Miami Dolphins. His zest for life extends to his role as a devoted father, spending time with his kids. His leadership role at Sapio Sciences is imbued with this same spirit, illustrating Kevin’s unwavering commitment to both his personal and professional pursuits.
Kevin Cramer
Founder & Chief Executive Officer
Kevin leverages a wealth of tech expertise to lead product design and development within the company.
Charles Ruprecht
Principal, GHO Capital
Charlie is an experienced investment professional with corporate finance experience, in Healthcare and Consumer.
Having joined GHO in 2022, Charlie works closely with the management team at Velocity Clinical Research.
Prior to GHO, Charlie was a VP at Webster Equity Partners where he was responsible for sourcing, evaluating, and executing deals across healthcare services and outsourced pharma. Charlie started his career in investment banking at Bank of America Merrill Lynch, where he advised clients across M&A, leveraged finance, and equity IPOs.
Charlie holds a Bachelor of Science from Boston University.
Charles Ruprecht
Principal, GHO Capital
Charlie is an experienced investment professional with corporate finance experience, in Healthcare and Consumer.
Mike Hampton
Chief Commercial Officer
Mike Hampton is the Chief Commercial Officer at Sapio Sciences, where he leads global commercial strategy and operations, including marketing, solution consulting, customer success and sales. He brings over two decades of international experience in life sciences, spanning commercial leadership, digital business transformation, and customer success.
Mike’s focus is on accelerating growth by developing strong partnerships with pharma and biotech and strengthening Sapio’s position as the industry leader in AI-native lab informatics. His career includes senior leadership roles at IDBS, a Danaher company, where he successfully scaled commercial teams and helped lead IDBS’s acquisition in 2017. Most recently, he served as Chief Revenue Officer and President of Field Operations at Causaly, where he partnered with top biopharma organizations with AI-powered solutions to empower scientists in achieving breakthrough discoveries. With deep expertise in R&D digital transformation, customer relationship development, and value-based engagements, Mike is passionate about helping customers accelerate the entire drug development lifecycle.
Mike Hampton
Chief Commercial Officer
Mike leverages over 20 years of global life sciences leadership to drive Sapio Sciences’ commercial strategy, customer success, and growth.
Andrew Wyatt
Chief Growth Officer, Strategic Partnerships
As Chief Growth Officer for Strategic Partnerships, Andrew Wyatt is responsible for growing Sapio’s international operations. He has over 30 years of expertise in commercially scaling global software companies. Andrew has worked in a wide range of organizations, from NASDAQ listed companies to privately held businesses, from the Communications sector to Life Sciences industry. Most recently Andrew was the COO of Lumeon, the leaders in healthcare orchestration where he successfully grew the business and entered the US market. With his deep understanding of the Life Sciences industry and proven ability to navigate the complexities of scaling operations, Andrew has consistently built organizations that delight customers while maximizing shareholder value.
Andrew Wyatt
Chief Growth Officer, Strategic Partnerships
Andrew is responsible for growing Sapio’s International operations.
Gordon McCall
Chief Financial Officer
Gordon McCall is an accomplished Chief Financial Officer (CFO) known for his ability to drive financial success and foster business growth. With a strong finance and accounting background, Gordon’s extensive experience positions him as a valuable asset in his role.
Having served as CFO for multiple organizations, Gordon has consistently scaled businesses and delivered exceptional results. His passion for supporting private equity-backed companies has honed his expertise in financial management, forecasting, fundraising, and mergers and acquisitions.
Gordon’s strategic mindset and hands-on approach provide valuable insights and guide informed decision-making in alignment with organizational goals. His ability to identify growth opportunities and see the bigger picture has been instrumental in driving sustainable success.
With a first-class degree in Finance and Accounting from Glasgow University and qualifications as a Chartered Accountant, Gordon’s academic background complements his practical experience, reflecting his commitment to professional excellence.
Beyond his professional accomplishments, Gordon values creating positive company cultures that foster collaboration and development. He prioritizes integrity and is passionate about empowering talented individuals to reach their full potential.
Outside of work, Gordon embraces his Scottish heritage and has a great sense of humor. He enjoys sports, particularly golf, which fuels his personal fulfillment.
As our Chief Financial Officer, Gordon McCall brings a wealth of knowledge, expertise, and a results-oriented approach to our organization. With his leadership, strategic thinking, and financial acumen, he is committed to driving our company’s financial success and supporting our growth trajectory, while maintaining a balanced and fulfilling personal life.
Gordon McCall
Chief Financial Officer
Gordon is an accomplished Chief Financial Officer (CFO) known for his ability to drive financial success and foster business growth.
Sean Blake
Chief Information Officer
Sean Blake has more than 20 years of IT leadership experience in technology operations, project management, systems implementation, and application support, with extensive expertise in regulatory compliance including 21 CFR Part 11, Sarbanes-Oxley, FISMA, FDA and US and International data privacy laws.
Having led complex projects across various companies in the pharmaceutical and biotechnology industries, Sean has proven his capabilities in executing critical IT strategies and guiding international, cross-functional, and multi-organizational teams.
Most recently he was the Chief Information Officer at BioAgilytix, where he was responsible for strategic planning, execution, and oversight for all Information Technology department functions globally in support of short and long-term business goals and in compliance with all applicable US and international regulations.
Sean has a BS in Information Systems Management from the University of Maryland Baltimore County, and a Masters Certificate in Advanced Information Assurance and Security from Villanova University, along with certifications in Certified in Risk and Information System Control ™ (CRISC) and Certified Information Systems Auditor® (CISA) from the Information Systems Audit and Control Association (ISACA).
Sean Blake
Chief Information Officer
Sean has more than 20 years of experience in technology operations, project management, systems implementation, and application support.
Rick Halton
Global Vice President of Marketing
Rick is the Vice President of Global Marketing at Sapio Sciences, where he leads the company’s global go-to-market strategy and brand positioning. With deep expertise in B2B enterprise software, Rick has a strong track record of scaling high-growth and startup technology companies, helping them define their market presence, accelerate customer acquisition, and drive revenue growth.
Prior to joining Sapio, Rick held senior marketing leadership roles across a range of innovative software businesses, including Apertio (real-time data management), Apervita (the first marketplace for clinical decision support algorithms), and Lumeon (the first healthcare automation platform). He also led marketing for a division of Hewlett Packard and served as Head of Business Marketing at Vodafone Spain.
Rick Halton
Global Vice President of Marketing
Rick brings a wealth of marketing experience across numerous B2B software platform businesses.
Rob Brown
Head of the Scientific Office
Rob Brown is Head of the Scientific Office at Sapio Sciences. He was previously at Dotmatics where he was Head of Global Presales, Product Marketing & Product Management. Earlier in his career he ran product marketing teams at Accelrys, SciTegic and MSI. Rob started his career as a postdoc and later research scientist at Abbott Laboratories (now Abbvie). He received his PhD in Cheminformatics from the University of Sheffield, UK.
Rob Brown
Head of the Scientific Office
Rob Brown is Head of the Scientific Office at Sapio Sciences.
Ricky Patel
Vice President of Technology Delivery
Ricky Patel is a forward-thinking, customer-focused software delivery leader based in London, UK. With a proven track record of building lean, agile, and high-performing teams, Ricky aligns strategic visions with precise tactical execution, consistently driving optimal business outcomes.
Equipped with a comprehensive skill set spanning Program and Software delivery, Agile methodologies, Compliance, Security, Cloud Computing, and more, Ricky’s professional journey is marked by transformative accomplishments and remarkable leadership.
Currently serving as the VP of Customer Success – EMEA at Sapio Sciences, Ricky operates at the forefront of scientific innovation. He is a vital contributor to the senior leadership team, guiding a diverse range of functions, including Program Management, Business Analysis, Solution Architecture, and Application Engineering. Ricky’s strategic oversight ensures that customers harness the full potential of the Sapio Sciences platform, leading to groundbreaking advancements and streamlined scientific processes.
In his role prior to Sapio Sciences, Ricky led the software development and global delivery of a transformative Care Orchestration platform. This innovative solution optimized hospital workflows, enhanced patient care, and scaled best practices across diverse healthcare environments.
Armed with a BSc in Computer Science and certifications in Scrum and advanced-level quality management, Ricky Patel is a dynamic professional poised to drive innovation and create enduring value in any technological landscape.
Ricky Patel
Vice President of Technology Delivery
Ricky is a forward-thinking, customer-focused software delivery leader based in London, UK.
Fran Carmody
Head of Customer Delivery
Fran Carmody serves as Head of Customer Delivery at Sapio Sciences, where he leads the execution of customer implementations, onboarding, and support services. With over 20 years of experience at the intersection of science and technology, Fran plays a pivotal role in ensuring seamless, high-quality customer experiences that drive measurable outcomes for Sapio’s clients.
Throughout his career, Fran has focused on helping life sciences organizations harness technology to accelerate innovation. Prior to joining Sapio, Fran held senior leadership positions at IDBS, where he served as Head of Global Professional Services and Services Enablement Manager. There, he worked closely with R&D, IT, and business leaders to deliver scalable, AI-driven digital lab solutions, while building high-performing services teams across global markets.
Fran’s expertise spans scientific informatics, SaaS solutions, and GxP environments, with a proven track record in project management, process optimization, and customer success. At Sapio Sciences, he is focused on optimizing service delivery frameworks and scaling operations to meet growing demand across biopharma R&D, clinical diagnostics, and manufacturing.
Fran Carmody
Head of Customer Delivery
Fran applies over 20 years of experience to lead customer delivery and drive service excellence at Sapio Sciences.
We’re always up to something exciting.
Do you want the latest on how Sapio is advancing our mission to simplify lab informatics for the love of science? Check out our newsroom, or explore our resource center for timely tools and insights.